Supplementary Table S2 from Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S2: Patient information and treatment regimen for OV-UM32.1, OV-UM50.2 and OV-UM52.1 cell lines.
创建时间：
2025-04-02
